The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Defining the mechanisms of response and resistance to anti-PD-1 therapy: An exploratory phase II study of pembrolizumab in advanced melanoma (ADAPTeM).
 
Kroopa Joshi
No Relationships to Disclose
 
Andrew J.S. Furness
No Relationships to Disclose
 
Theres Oakes
No Relationships to Disclose
 
James Heather
No Relationships to Disclose
 
Lavinia Anne Spain
No Relationships to Disclose
 
Yien Ning Sophia Wong
No Relationships to Disclose
 
Assma Ben Aissa
No Relationships to Disclose
 
Mark Stares
No Relationships to Disclose
 
Myles JF Smith
No Relationships to Disclose
 
Dirk C Strauss
No Relationships to Disclose
 
Andrew J Hayes
No Relationships to Disclose
 
Teresa Marafioti
No Relationships to Disclose
 
Samra Turajlic
No Relationships to Disclose
 
Martin Eric Gore
No Relationships to Disclose
 
Karl Peggs
Consulting or Advisory Role - Autolus; Basilea; Chimerix; Clinigen Group; Merck; Takeda
Speakers' Bureau - Merck; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Cell Medica; Merck; Takeda
 
Benjamin Chain
No Relationships to Disclose
 
Sergio Quezada
No Relationships to Disclose
 
James M. G. Larkin
Research Funding - Novartis (Inst); Pfizer (Inst)